Question

Difficulty: HardGastroenterology and Hepatology

During morning rounds, the clinical team reviews the status of a patient who was hospitalized four days ago due to massive ascites and lower extremity edema. The patient has long-standing cirrhosis secondary to chronic hepatitis C virus infection. Despite medication compliance prior to admission, his weight had increased significantly over the preceding month. Current vital signs include a temperature of 36.9∘C36.9^\circ\text{C} (98.4∘F98.4^\circ\text{F}), blood pressure of 92/56 mmHg92/56\text{ mmHg}, and heart rate of 94/min94/\text{min}. Physical examination reveals a tensely distended abdomen with a positive fluid wave and bilateral pitting edema extending to the thighs. The lungs are clear to auscultation. Recent laboratory values show a serum sodium of 131 mEq/L131\text{ mEq/L}, serum potassium of 4.2 mEq/L4.2\text{ mEq/L}, serum bicarbonate of 17 mEq/L17\text{ mEq/L}, blood urea nitrogen of 55 mg/dL55\text{ mg/dL}, and serum creatinine of 2.8 mg/dL2.8\text{ mg/dL} (baseline was 1.0 mg/dL1.0\text{ mg/dL} three weeks prior). A diagnostic paracentesis performed upon admission showed an absolute neutrophil count of 110/mm3110/\text{mm}^3. Urinalysis demonstrates no red blood cells, white blood cells, or casts, and the urine sodium concentration is 8 mEq/L8\text{ mEq/L}. Renal ultrasonography reveals normal renal architecture without obstruction. Over the past 48 hours, all diuretic therapy was withheld, and the patient was administered intravenous albumin at 1 g/kg1\text{ g/kg} per day. Today, his serum creatinine remains elevated at 2.9 mg/dL2.9\text{ mg/dL}. Which of the following is the most appropriate next step in management?

  1. Administration of midodrine and octreotideAnswer
  2. B
    Computed tomography of the abdomen with intravenous contrast
  3. C
    Intravenous furosemide infusion
  4. D
    Intravenous piperacillin-tazobactam
  5. E
    Intravenous sodium bicarbonate

Answer

The most appropriate next step is the administration of splanchnic vasoconstrictors, such as midodrine and octreotide, to counteract the systemic vasodilation causing hepatorenal syndrome.
This patient's clinical presentation confirms the diagnosis of hepatorenal syndrome (HRS). HRS is a severe complication of advanced cirrhosis characterized by progressive functional renal failure. Portal hypertension triggers the release of local vasodilators (e.g., nitric oxide), causing profound splanchnic arterial vasodilation. This massively decreases the effective arterial blood volume, prompting a compensatory but ultimately detrimental systemic response: intense activation of the renin-angiotensin-aldosterone system and the sympathetic nervous system. The result is severe renal vasoconstriction and acute kidney injury. The diagnosis is clinical, defined by AKI that does not improve after 48 hours of diuretic withdrawal and volume expansion with intravenous albumin, alongside the exclusion of shock, nephrotoxic agents, and intrinsic kidney disease (evidenced here by a bland urinalysis and normal ultrasound). The definitive medical management for HRS aims to reverse the splanchnic vasodilation. In the United States, standard pharmacotherapy consists of midodrine (an alpha-1 adrenergic agonist to promote systemic vasoconstriction), octreotide (a somatostatin analog to inhibit endogenous splanchnic vasodilators), and continued intravenous albumin.

Step-by-Step Solution

1
Identify the primary pathology based on the clinical presentation and laboratory results.
The patient has advanced cirrhosis with new-onset severe acute kidney injury (creatinine increased from 1.0 to 2.8 mg/dL).
Recognizing the AKI in the context of portal hypertension is the first step in formulating a differential diagnosis for renal failure in liver disease.
2
Evaluate the response to initial interventions and rule out other causes of AKI.
The AKI failed to improve after 48 hours of diuretic withdrawal and aggressive volume expansion with intravenous albumin. SBP, shock, and intrinsic renal disease are ruled out.
Failure to respond to albumin and diuretic cessation specifically fulfills the diagnostic criteria for hepatorenal syndrome (HRS).
3
Determine the appropriate definitive medical therapy for the diagnosed condition.
Select administration of midodrine and octreotide.
HRS is caused by profound splanchnic vasodilation. Therapy must target reversing this vasodilation to restore renal perfusion.

Key Concept

Diagnosis and management of Hepatorenal Syndrome (HRS)
Rate this question